Drug Free Solution, Inc. (DSOL)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2020 | 2019 | 2018 | 2017 | 2013 |
|---|---|---|---|---|---|
| Revenue | 805.00 | 1766.00 | - | 150.09 Thousand | - |
| Cost of Revenue | - | 11 Thousand | 1975.00 | - | 972.00 |
| Gross Profit | 805.00 | -9234.00 | -1975.00 | 150.09 Thousand | -972.00 |
| Operating Expenses | 1.39 Million | 1.44 Million | 231.35 Thousand | 209.15 Thousand | 754.89 Thousand |
| Selling, General and Administrative Expenses | 1.39 Million | 1.44 Million | 231.35 Thousand | 209.15 Thousand | 754.89 Thousand |
| Research and Development Expenses | - | - | - | - | - |
| Other Expenses | - | - | - | - | - |
| Cost and Expenses | 1.4 Million | 1.45 Million | 233.33 Thousand | 217.18 Thousand | 755.86 Thousand |
| Operating Income | -1.4 Million | -1.44 Million | -233.33 Thousand | -67.09 Thousand | -755.87 Thousand |
| Interest Expense | - | 3113.00 | - | - | - |
| Income Tax Expense | 2.00 | -1.00 | -5.00 | 2.00 | -2.00 |
| Earnings before Tax | -1.4 Million | -1.45 Million | -233.33 Thousand | -67.09 Thousand | -755.86 Thousand |
| Net Income | -1.4 Million | -1.45 Million | -233.33 Thousand | -67.09 Thousand | -755.86 Thousand |
| Earnings Per Share Basic | -0.00 | -0.01 | -0.00 | -0.00 | -0.01 |
| Earnings Per Share Diluted | -0.00 | -0.01 | -0.00 | -0.00 | -0.01 |
| Weighted Average Shares Outstanding | 427.63 Million | 129.09 Million | 61.56 Million | 49.44 Million | 71.74 Million |
| Weighted Average Shares Outstanding (Diluted) | 427.63 Million | 129.09 Million | 61.56 Million | 49.44 Million | 71.74 Million |
| Gross Margin | 1.00 | -5.23 | - | 1.00 | - |
| EBIT Margin | -1732.83 | -817.29 | - | -0.39 | - |
| Profit Margin | -1748.17 | -822.43 | - | -0.45 | - |
| EBITDA | -1.39 Million | -1.44 Million | -231.35 Thousand | -59.06 Thousand | -754.89 Thousand |
| Earnings Before Tax Margin | -1748.17 | -820.67 | - | -0.45 | - |
| Breakdown | 2020 Q3 | 2019 FY | 2018 FY | 2017 FY | 2016 FY | 2013 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | 805.00 | 1766.00 | - | 150.09 Thousand | - |
| Cost of Revenue | - | - | 11 Thousand | 1975.00 | - | - |
| Gross Profit | - | 805.00 | -9234.00 | -1975.00 | 150.09 Thousand | - |
| Operating Expenses | 1943.00 | 1.39 Million | 1.44 Million | 231.35 Thousand | 209.15 Thousand | 120.35 |
| Selling, General and Administrative Expenses | 1943.00 | - | - | - | - | 120.35 |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 1943.00 | 1.4 Million | 1.45 Million | 233.33 Thousand | 217.18 Thousand | 120.35 |
| Operating Income | -1940.00 | -1.4 Million | -1.44 Million | -233.33 Thousand | -67.09 Thousand | -120.35 |
| Interest Expense | - | - | 3113.00 | - | - | - |
| Income Tax Expense | - | 2.00 | -1.00 | -5.00 | 2.00 | - |
| Earnings before Tax | -1943.00 | -1.4 Million | -1.45 Million | -233.33 Thousand | -67.09 Thousand | -120.35 |
| Net Income | -1943.00 | -1.4 Million | -1.45 Million | -233.33 Thousand | -67.09 Thousand | -120.35 |
| Earnings Per Share Basic | - | - | - | - | - | -0.00 |
| Earnings Per Share Diluted | - | - | - | - | - | -0.00 |
| Weighted Average Shares Outstanding | 444.45 Million | 427.63 Million | 129.09 Million | 61.56 Million | 49.44 Million | 105.01 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 444.45 Million | 427.63 Million | 129.09 Million | 61.56 Million | 49.44 Million | 104.92 Thousand |
| Gross Margin | - | 1.00 | -5.23 | - | 1.00 | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | -1748.17 | -822.43 | - | -0.45 | - |
| EBITDA | -1940.00 | - | - | - | - | -116.84 |
| Earnings Before Tax Margin | - | -1748.17 | -820.67 | - | -0.45 | - |
214420
DGNG
OMID
ATLANTAA
III
STHI